The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes.
To assess whether patients' willingness to add a blood pressure-lowering drug and the importance they attach to specific treatment characteristics differ among age groups in patients with type 2 diabetes.Patients being prescribed at least an oral glucose-lowering and a blood pressure-lowering d...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4596700?pdf=render |
id |
doaj-cee654b72e5a4bc999ed7b05fd9193da |
---|---|
record_format |
Article |
spelling |
doaj-cee654b72e5a4bc999ed7b05fd9193da2020-11-25T00:49:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011010e013975510.1371/journal.pone.0139755The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes.Sieta T de VriesFolgerdiena M de VriesThijs DekkerFlora M Haaijer-RuskampDick de ZeeuwAdelita V RanchorPetra DenigTo assess whether patients' willingness to add a blood pressure-lowering drug and the importance they attach to specific treatment characteristics differ among age groups in patients with type 2 diabetes.Patients being prescribed at least an oral glucose-lowering and a blood pressure-lowering drug completed a questionnaire including a discrete choice experiment. This experiment contained choice sets with hypothetical blood pressure-lowering drugs and a no additional drug alternative, which differed in their characteristics (i.e. effects and intake moments). Differences in willingness to add a drug were compared between patients <75 years (non-aged) and ≥75 years (aged) using Pearson χ²-tests. Multinomial logit models were used to assess and compare the importance attached to the characteristics.Of the 161 patients who completed the questionnaire, 151 (72%) could be included in the analyses (mean age 68 years; 42% female). Aged patients were less willing to add a drug than non-aged patients (67% versus 84% respectively; P = 0.017). In both age groups, the effect on blood pressure was most important for choosing a drug, followed by the risk of adverse drug events and the risk of death. The effect on limitations due to stroke was only significant in the non-aged group. The effect on blood pressure was slightly more important in the non-aged than the aged group (P = 0.043).Aged patients appear less willing to add a preventive drug than non-aged patients. The importance attached to various treatment characteristics does not seem to differ much among age groups.http://europepmc.org/articles/PMC4596700?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sieta T de Vries Folgerdiena M de Vries Thijs Dekker Flora M Haaijer-Ruskamp Dick de Zeeuw Adelita V Ranchor Petra Denig |
spellingShingle |
Sieta T de Vries Folgerdiena M de Vries Thijs Dekker Flora M Haaijer-Ruskamp Dick de Zeeuw Adelita V Ranchor Petra Denig The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes. PLoS ONE |
author_facet |
Sieta T de Vries Folgerdiena M de Vries Thijs Dekker Flora M Haaijer-Ruskamp Dick de Zeeuw Adelita V Ranchor Petra Denig |
author_sort |
Sieta T de Vries |
title |
The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes. |
title_short |
The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes. |
title_full |
The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes. |
title_fullStr |
The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes. |
title_full_unstemmed |
The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes. |
title_sort |
role of patients' age on their preferences for choosing additional blood pressure-lowering drugs: a discrete choice experiment in patients with diabetes. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2015-01-01 |
description |
To assess whether patients' willingness to add a blood pressure-lowering drug and the importance they attach to specific treatment characteristics differ among age groups in patients with type 2 diabetes.Patients being prescribed at least an oral glucose-lowering and a blood pressure-lowering drug completed a questionnaire including a discrete choice experiment. This experiment contained choice sets with hypothetical blood pressure-lowering drugs and a no additional drug alternative, which differed in their characteristics (i.e. effects and intake moments). Differences in willingness to add a drug were compared between patients <75 years (non-aged) and ≥75 years (aged) using Pearson χ²-tests. Multinomial logit models were used to assess and compare the importance attached to the characteristics.Of the 161 patients who completed the questionnaire, 151 (72%) could be included in the analyses (mean age 68 years; 42% female). Aged patients were less willing to add a drug than non-aged patients (67% versus 84% respectively; P = 0.017). In both age groups, the effect on blood pressure was most important for choosing a drug, followed by the risk of adverse drug events and the risk of death. The effect on limitations due to stroke was only significant in the non-aged group. The effect on blood pressure was slightly more important in the non-aged than the aged group (P = 0.043).Aged patients appear less willing to add a preventive drug than non-aged patients. The importance attached to various treatment characteristics does not seem to differ much among age groups. |
url |
http://europepmc.org/articles/PMC4596700?pdf=render |
work_keys_str_mv |
AT sietatdevries theroleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes AT folgerdienamdevries theroleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes AT thijsdekker theroleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes AT floramhaaijerruskamp theroleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes AT dickdezeeuw theroleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes AT adelitavranchor theroleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes AT petradenig theroleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes AT sietatdevries roleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes AT folgerdienamdevries roleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes AT thijsdekker roleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes AT floramhaaijerruskamp roleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes AT dickdezeeuw roleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes AT adelitavranchor roleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes AT petradenig roleofpatientsageontheirpreferencesforchoosingadditionalbloodpressureloweringdrugsadiscretechoiceexperimentinpatientswithdiabetes |
_version_ |
1725252343629348864 |